Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Phair Pricing Act of 2019
Client: AIDS HEALTHCARE FOUNDATION · Firm: PARRY, ROMANI, DECONCINI & SYMMS
To Address Pharmacy DIR fees in next CoVid19 package. H.R.1034 the Phair Drug Pricing Act of 2019. S640 the Phair Drug Pricing Act of 2019. S2543 Grassley/Wyden's Prescription Drug Pricing Reduction Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: AIDS HEALTHCARE FOUNDATION · Firm: PARRY, ROMANI, DECONCINI & SYMMS
To Address Pharmacy DIR fees in next CoVid19 package. H.R.1034 the Phair Drug Pricing Act of 2019. S640 the Phair Drug Pricing Act of 2019. S2543 Grassley/Wyden's Prescription Drug Pricing Reduction Act of 2019
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AIDS HEALTHCARE FOUNDATION via PARRY, ROMANI, DECONCINI & SYMMS
2020 · first_quarter · Q1
To Address Pharmacy DIR fees in next CoVid19 package. H.R.1034 the Phair Drug Pricing Act of 2019. S640 the Phair Drug Pricing Act of 2019. S2543 Grassley/Wyden's Prescription Drug Pricing Reduction Act of 2019
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RESEARCH CORPORATION TECHNOLOGY via PARRY, ROMANI, DECONCINI & SYMMS
2020 · first_quarter · Q1
Source: Senate LDA
| BART & ASSOCIATES INC |
| 32 |
| 2007–2015 |
| SANOFI US SERVICES INC (FORMERLY KNOWN AS "SANOFI-AVENTIS U S INC ) | 27 | 2004–2017 |
| AMERICAN SOCIETY OF ASSN EXECUTIVES | 23 | 2004–2015 |
| MARICOPA COMMUNITY COLLEGE | 20 | 2004–2011 |
| WOMEN'S INTERNATIONAL PHARMACY INC | 19 | 2008–2012 |
| ROCK & ASSOCIATES | 18 | 2015–2018 |
| WEDGEWOOD VILLAGE PHARMACY, INC. | 18 | 2008–2012 |
| AMERICAN ASSOCIATION FOR HEALTH FREEDOM | 15 | 2008–2012 |
| BRAIDWOOD MANAGEMENT, INC. | 13 | 2008–2011 |
| VETERINARY PHARMACIES OF AMERICA, INC. | 11 | 2008–2011 |
| AMGEN USA, INC. | 10 | 2010–2013 |
| INTL ACADEMY OF COMPOUNDING PHARMACISTS | 10 | 2006–2009 |
| PLASMA PROTEIN THERAPEUTICS ASSOCIATION | 9 | 2007–2009 |
| APIC CORPORATION | 8 | 2004–2009 |
| ASPHALT SYSTEMS INC | 8 | 2004–2008 |
| HOFFMANN-LA ROCHE INC | 8 | 2004–2007 |
| NETWORTH SERVICES, INC | 8 | 2004–2007 |
| XINERGY CORP | 8 | 2011–2012 |
| AMERICAN ECOLOGY CORP | 7 | 2004–2007 |
| CONSERVATION TRUST OF PUERTO RICO | 7 | 2004–2007 |
| HEALTHY DIRECTIONS LLC | 7 | 2007–2008 |
| PRUDENTIAL SECURITIES INC | 7 | 2004–2007 |
| AMERICAN MEDIA INC | 6 | 2004–2006 |
| BURNS DEVELOPMENT COMPANY INC | 6 | 2008 |
| CENTERLINE | 6 | 2005–2007 |
| COALITION TO PRESERVE DSHEA | 6 | 2009–2010 |
| KOPPERS INDUSTRIES | 6 | 2004–2006 |
| MEDICIS PHARMACEUTICAL CORPORATION | 6 | 2007–2008 |
| SIDLEY AUSTIN LLP (FOR SEPRACOR) | 6 | 2006–2008 |
| CHIRON CORP | 5 | 2004–2006 |
| DIAMONDBACK DRUGS | 5 | 2010–2011 |
| EDUCATIONAL OPTIONS, INC. | 5 | 2005–2007 |
| FRIENDS OF THE 9TH CIRCUIT | 5 | 2006 |
| GENERAL MOTORS CORPORATION | 5 | 2005–2007 |
| INTL INTERACTIVE ALLIANCE | 5 | 2005–2006 |
| PARTYGAMING | 5 | 2007–2008 |
| RECORDING INDUSTRY ASSN OF AMERICA | 5 | 2004–2005 |
| TRACFONE WIRELESS | 5 | 2005–2006 |
| AKIN & PORTER PRODUCE | 4 | 2018–2019 |
| ALABAMA-COUSHATTA TRIBE OF TEXAS | 4 | 2007–2015 |
| BRANDT MILES | 4 | 2017–2018 |
| CMTE TO ADVANCE COMPOUNDING PHARMACY | 4 | 2004–2005 |
| E-LOTTERY | 4 | 2005–2007 |
| NATIONAL STRATEGIES, LLC (ON BEHALF OF BIDZINA IVANISHVILI) | 4 | 2012 |
| NOVARTIS CORP | 4 | 2006–2007 |
| PANDORA MEDIA, INC. | 4 | 2008 |
| YAVAPAI COLLEGE | 4 | 2009–2010 |
| ANAGENESIS TREES CORPORATION | 3 | 2007 |
| AUTHENTIX | 3 | 2007 |
| AUTISM SOCIETY OF AMERICA | 3 | 2004–2005 |
| DORSEY & WHITNEY | 3 | 2004–2005 |
| DR. MUDHAR SHAWKAT | 3 | 2015 |
| EMPIRE RESORTS | 3 | 2004–2005 |
| FREEDMAN BOYD DANIELS HOLLANDER GOLDBERG & CLINE | 3 | 2004 |
| MILLENNIUM PHARMACEUTICAL | 3 | 2007 |
| PFIZER | 3 | 2004–2005 |
| BNG ENTERPRISES | 2 | 2005 |
| FRIENDS OF LA COURTHOUSE | 2 | 2008 |
| ICVN INC | 2 | 2004–2005 |
| LYONDELL CHEMICAL CO | 2 | 2004 |
| MOTION PICTURE ASSN OF AMERICA | 2 | 2004 |
| NC9 GROUP TRUST | 2 | 2015 |
| SMITH DAWSON & ANDREWS | 2 | 2005 |
| STANFORD FINANCIAL GROUP | 2 | 2005–2006 |
| STAR SCIENTIFIC, INC. - ROCK CREEK PHARMACEUTICALS, INC. | 2 | 2010 |
| UNITED SUPPLEMENT FREEDOM ASSN | 2 | 2004 |
| USPLABS | 2 | 2013 |
| ACCENTURE | 1 | 2004 |
| BANK OF NEW YORK | 1 | 2004 |
| CONGOLEUM CORP | 1 | 2004 |
| KWIKMED | 1 | 2009 |
| NORTHWEST INDIANA CONSULTANTS LLC (FOR MIAMI TRIBE OF OKLAHOMA) | 1 | 2006 |
| OSI PHARMACEUTICALS, INC. | 1 | 2009 |
| SPOKANE TRIBE | 1 | 2006 |
| WEST COAST RESEARCH AND MANAGEMENT SERVICE, INC. | 1 | 2014 |
| WINDOW ROCK ENTERPRISES INC | 1 | 2005 |
Phair Pricing Act of 2019
Client: AIDS HEALTHCARE FOUNDATION · Firm: PARRY, ROMANI, DECONCINI & SYMMS
To Address Pharmacy DIR fees in next CoVid19 package. H.R.1034 the Phair Drug Pricing Act of 2019. S640 the Phair Drug Pricing Act of 2019. S2543 Grassley/Wyden's Prescription Drug Pricing Reduction Act of 2019
Consolidated Appropriations Act, 2018
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Appropriations to fund the FDA implementation of compounding pharmacy regulations: H.R. 1625, Consolidated Appropriations Act 2018
Consolidated Appropriations Act, 2018
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Appropriations to fund the FDA implementation of compounding pharmacy regulations: H.R. 1625, Consolidated Appropriations Act 2018
Consolidated Appropriations Act, 2018
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Appropriations to fund the FDA implementation of compounding pharmacy regulations: H.R. 1625, Consolidated Appropriations Act 2018
Consolidated Appropriations Act, 2018
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Appropriations to fund the FDA implementation of compounding pharmacy regulations; H.R. 1625, Consolidated Appropriations Act, 2018.
Agriculture Improvement Act of 2018
Client: GENERAL NUTRITION CENTER · Firm: PARRY, ROMANI, DECONCINI & SYMMS
H.R.2-Agriculture and Nutrition Act of 2018 (The Farm Bill) S3042 Agriculture and Nutrition Act of 2018 (The Farm Bill)
Jerusalem Embassy and Recognition Act of 2017
Client: GENERAL NUTRITION CENTER · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Trade issues affecting Farm Bill #H.R.265
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Agriculture Improvement Act of 2018
Client: GENERAL NUTRITION CENTER · Firm: PARRY, ROMANI, DECONCINI & SYMMS
H.R.2-Agriculture and Nutrition Act of 2018 (The Farm Bill) S3042 Agriculture and Nutrition Act of 2018 (The Farm Bill)
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: VERIZON GOVERNMENT RELATIONS · Firm: PARRY, ROMANI, DECONCINI & SYMMS
H.R. 1, Tax Cuts and Jobs Act. (An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.)
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Preserving Patient Access to Compounded Medications Act of 2017
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Social Security Online Tools Innovation Act of 2018
Client: RESEARCH CORPORATION TECHNOLOGY · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.
21st Century Cures Act
Client: SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Issues related to the 21st Century Cures Initiative, including all provisions of H.R. 6, To accelerate the discovery, development, and delivery of 21st century cures and for other purposes (21st Century Cures Act). Issues related to the need for research into clinical tools to diagnose and assess the severity of atopic dermatitis.
Patent Abuse Reduction Act of 2013
Client: RESEARCH CORPORATION TECHNOLOGY · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.
Patent Litigation Integrity Act of 2013
Client: RESEARCH CORPORATION TECHNOLOGY · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.
Digital Goods and Services Tax Fairness Act of 2015
Client: VERIZON GOVERNMENT RELATIONS · Firm: PARRY, ROMANI, DECONCINI & SYMMS
S. 851, Digital Goods and Tax Services Fairness Act H.R. 1643, Digital Goods and Tax Services Fairness Act
Digital Goods and Services Tax Fairness Act of 2015
Client: VERIZON GOVERNMENT RELATIONS · Firm: PARRY, ROMANI, DECONCINI & SYMMS
S. 851, Digital Goods and Tax Services Fairness Act H.R. 1643, Digital Goods and Tax Services Fairness Act
Digital Goods and Services Tax Fairness Act of 2015
Client: VERIZON GOVERNMENT RELATIONS · Firm: PARRY, ROMANI, DECONCINI & SYMMS
S. 851, Digital Goods and Tax Services Fairness Act H.R. 1643, Digital Goods and Tax Services Fairness Act
Permanent Internet Tax Freedom Act
Client: VERIZON GOVERNMENT RELATIONS · Firm: PARRY, ROMANI, DECONCINI & SYMMS
HR. 235, Permanent Internet Tax Freedom Act S. 431, Internet Tax Freedom Forever Act
Flex-IT 2 Act
Client: RESEARCH CORPORATION TECHNOLOGY · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.
Flex-IT 2 Act
Client: RESEARCH CORPORATION TECHNOLOGY · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.
Flex-IT 2 Act
Client: RESEARCH CORPORATION TECHNOLOGY · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.
Flex-IT 2 Act
Client: RESEARCH CORPORATION TECHNOLOGY · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Appropriations (H.R. 5054 and S. 2956) to fund the FDA implementation of compounding pharmacy regulations.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Appropriations (H.R. 5054 and S. 2956) to fund the FDA implementation of compounding pharmacy regulations.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Appropriations (H.R. 5054 and S. 2956) to fund the FDA implementation of compounding pharmacy regulations.
21st Century Cures Act
Client: SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Issues related to the 21st Century Cures Initiative, including all provisions of H.R. 6, To accelerate the discovery, development, and delivery of 21st century cures and for other purposes (21st Century Cures Act). Issues related to the need for research into clinical tools to diagnose and assess the severity of atopic dermatitis. Issues related to insulin and vaccines, no specific legislation.
Email Privacy Act
Client: VERIZON GOVERNMENT RELATIONS · Firm: PARRY, ROMANI, DECONCINI & SYMMS
S. 356, Electronic Communications Privacy Act Amendments Act of 2015 H.R. 699, Email Privacy Act
Email Privacy Act
Client: VERIZON GOVERNMENT RELATIONS · Firm: PARRY, ROMANI, DECONCINI & SYMMS
S. 356, Electronic Communications Privacy Act Amendments Act of 2015 H.R. 699, Email Privacy Act
HR. 9, Innovation Act S. 1137, The Patent Act
HR. 9, Innovation Act S. 1137, The Patent Act
Innovation Act
Client: SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored consideration of patent legislation; international intellectual property issues; general issues related to patent settlements; and all provisions of H.R. 9, the Innovation Act; and S. 1137, Protecting American Talent and Entrepeneurship Act of 2015.
Innovation Act
Client: SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored consideration of patent legislation; international intellectual property issues; general issues related to patent settlements; and all provisions of H.R. 9, the Innovation Act; and S. 1137, Protecting American Talent and Entrepeneurship Act of 2015.
HR. 9, Innovation Act S. 1137, The Patent Act
Innovation Act
Client: SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored consideration of patent legislation; international intellectual property issues; general issues related to patent settlements; and all provisions of H.R. 9, the Innovation Act; and S. 1137, Protecting American Talent and Entrepeneurship Act of 2015.
HR. 9, Innovation Act S. 1137, The Patent Act
PATENT Act
Client: SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored consideration of patent legislation; international intellectual property issues; general issues related to patent settlements; and all provisions of H.R. 9, the Innovation Act; and S. 1137, Protecting American Talent and Entrepeneurship Act of 2015.
S. 1137, The Patent Act
HR. 9, Innovation Act S. 1137, The Patent Act
PATENT Act
Client: SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored consideration of patent legislation; international intellectual property issues; general issues related to patent settlements; and all provisions of H.R. 9, the Innovation Act; and S. 1137, Protecting American Talent and Entrepeneurship Act of 2015.
HR. 9, Innovation Act S. 1137, The Patent Act
PATENT Act
Client: SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored consideration of patent legislation; international intellectual property issues; general issues related to patent settlements; and all provisions of H.R. 9, the Innovation Act; and S. 1137, Protecting American Talent and Entrepeneurship Act of 2015.
Saving Access to Compounded Medications for Special Needs Patients Act
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Saving Access to Compounded Medications for Special Needs Patients Act
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Saving Access to Compounded Medications for Special Needs Patients Act
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Saving Access to Compounded Medications for Special Needs Patients Act
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Unified Savings and Accountability Act
Client: SICPA SECURINK CORP · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored and opposed legislative efforts affecting U.S. currency; specifically provisions which sought to eliminate the dollar bill and expand the circulation of dollar coins. Monitored provisions in the budget resolution affecting the scoring of proposals that would eliminate the dollar bill. S. 1888, Unified Savings and Accountability Act or the USA Act.
Unified Savings and Accountability Act
Client: SICPA SECURINK CORP · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored and opposed legislative efforts affecting U.S. currency; specifically provisions which sought to eliminate the dollar bill and expand the circulation of dollar coins. Monitored provisions in the budget resolution affecting the scoring of proposals that would eliminate the dollar bill. S. 1888, Unified Savings and Accountability Act or the USA Act.
Unified Savings and Accountability Act
Client: SICPA SECURINK CORP · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored and opposed legislative efforts affecting U.S. currency; specifically provisions which sought to eliminate the dollar bill and expand the circulation of dollar coins. Monitored provisions in the budget resolution affecting the scoring of proposals that would eliminate the dollar bill. S. 1888, Unified Savings and Accountability Act or the USA Act.
Unified Savings and Accountability Act
Client: SICPA SECURINK CORP · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored and opposed legislative efforts affecting U.S. currency; specifically provisions which sought to eliminate the dollar bill and expand the circulation of dollar coins. Monitored provisions in the budget resolution affecting the scoring of proposals that would eliminate the dollar bill. S. 1888, Unified Savings and Accountability Act or the USA Act.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Appropriations (H.R. 5054 and S. 2956) to fund the FDA implementation of compounding pharmacy regulations.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Appropriations (H.R. 5054 and S. 2956) to fund the FDA implementation of compounding pharmacy regulations.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017
Client: ROCK & ASSOCIATES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Appropriations (H.R. 5054 and S. 2956) to fund the FDA implementation of compounding pharmacy regulations.
Electronic Communications Privacy Act Amendments Act of 2015
Client: VERIZON GOVERNMENT RELATIONS · Firm: PARRY, ROMANI, DECONCINI & SYMMS
S. 356, Electronic Communications Privacy Act Amendments Act of 2015
Electronic Communications Privacy Act Amendments Act of 2015
Client: VERIZON GOVERNMENT RELATIONS · Firm: PARRY, ROMANI, DECONCINI & SYMMS
S. 356, Electronic Communications Privacy Act Amendments Act of 2015 H.R. 699, Email Privacy Act
Electronic Communications Privacy Act Amendments Act of 2015
Client: VERIZON GOVERNMENT RELATIONS · Firm: PARRY, ROMANI, DECONCINI & SYMMS
S. 356, Electronic Communications Privacy Act Amendments Act of 2015
Electronic Communications Privacy Act Amendments Act of 2015
Client: VERIZON GOVERNMENT RELATIONS · Firm: PARRY, ROMANI, DECONCINI & SYMMS
S. 356, Electronic Communications Privacy Act Amendments Act of 2015 H.R. 699, Email Privacy Act
Internet Tax Freedom Forever Act
Client: VERIZON GOVERNMENT RELATIONS · Firm: PARRY, ROMANI, DECONCINI & SYMMS
HR. 235, Permanent Internet Tax Freedom Act S. 431, Internet Tax Freedom Forever Act
Digital Goods and Services Tax Fairness Act of 2015
Client: VERIZON GOVERNMENT RELATIONS · Firm: PARRY, ROMANI, DECONCINI & SYMMS
S. 851, Digital Goods and Tax Services Fairness Act H.R. 1643, Digital Goods and Tax Services Fairness Act
Digital Goods and Services Tax Fairness Act of 2015
Client: VERIZON GOVERNMENT RELATIONS · Firm: PARRY, ROMANI, DECONCINI & SYMMS
S. 851, Digital Goods and Tax Services Fairness Act H.R. 1643, Digital Goods and Tax Services Fairness Act
Digital Goods and Services Tax Fairness Act of 2015
Client: VERIZON GOVERNMENT RELATIONS · Firm: PARRY, ROMANI, DECONCINI & SYMMS
S. 851, Digital Goods and Tax Services Fairness Act H.R. 1643, Digital Goods and Tax Services Fairness Act
Patent Abuse Reduction Act of 2013
Client: RESEARCH CORPORATION TECHNOLOGY · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.
Patent Abuse Reduction Act of 2013
Client: RESEARCH CORPORATION TECHNOLOGY · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.
Patent Abuse Reduction Act of 2013
Client: RESEARCH CORPORATION TECHNOLOGY · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.
Patent Abuse Reduction Act of 2013
Client: RESEARCH CORPORATION TECHNOLOGY · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.
Patent Litigation Integrity Act of 2013
Client: RESEARCH CORPORATION TECHNOLOGY · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.
Patent Litigation Integrity Act of 2013
Client: RESEARCH CORPORATION TECHNOLOGY · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.
Patent Litigation Integrity Act of 2013
Client: RESEARCH CORPORATION TECHNOLOGY · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.
Patent Litigation Integrity Act of 2013
Client: RESEARCH CORPORATION TECHNOLOGY · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.
Consolidated Appropriations Act, 2016
Client: VERIZON GOVERNMENT RELATIONS · Firm: PARRY, ROMANI, DECONCINI & SYMMS
HR. 235, Permanent Internet Tax Freedom Act S. 431, Internet Tax Freedom Forever Act HR. 2029, Consolidated Appropriations Act 2016
GSA Act of 2015
Client: AMERICAN SOCIETY OF ASSN EXECUTIVES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
S. 1347, The Conference Accountability Act of 2013. Legislation related to federal travel and attendance by federal employees at meetings and conventions, and to information required to be posted on federal websites related to government sponsored conferences. No specific legislation introduced yet. H.R. 2810, Stay in Place, Cut the Waste, calls for agencies to cut travel budgets as much as 50% of 2015 levels by using videoconferencing as a substitute for face-to-face meetings. H.R. 2032, to institute spending limits and transparency requirements for Federal conference and travel expenditures, and for other purposes.
GSA Act of 2015
Client: AMERICAN SOCIETY OF ASSN EXECUTIVES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
S. 1347, The Conference Accountability Act of 2013. Legislation related to federal travel and attendance by federal employees at meetings and conventions, and to information required to be posted on federal websites related to government sponsored conferences. No specific legislation introduced yet. H.R. 2810, Stay in Place, Cut the Waste, calls for agencies to cut travel budgets as much as 50% of 2015 levels by using videoconferencing as a substitute for face-to-face meetings. H.R. 2032, to institute spending limits and transparency requirements for Federal conference and travel expenditures, and for other purposes.
GSA Act of 2015
Client: AMERICAN SOCIETY OF ASSN EXECUTIVES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
S. 1347, The Conference Accountability Act of 2013. Legislation related to federal travel and attendance by federal employees at meetings and conventions, and to information required to be posted on federal websites related to government sponsored conferences. No specific legislation introduced yet. H.R. 2810, Stay in Place, Cut the Waste, calls for agencies to cut travel budgets as much as 50% of 2015 levels by using videoconferencing as a substitute for face-to-face meetings. H.R. 2032, to institute spending limits and transparency requirements for Federal conference and travel expenditures, and for other purposes.
Permanent Internet Tax Freedom Act
Client: VERIZON GOVERNMENT RELATIONS · Firm: PARRY, ROMANI, DECONCINI & SYMMS
HR. 235, Permanent Internet Tax Freedom Act S. 431, Internet Tax Freedom Forever Act
Permanent Internet Tax Freedom Act
Client: VERIZON GOVERNMENT RELATIONS · Firm: PARRY, ROMANI, DECONCINI & SYMMS
HR. 235, Permanent Internet Tax Freedom Act S. 431, Internet Tax Freedom Forever Act
Permanent Internet Tax Freedom Act
Client: VERIZON GOVERNMENT RELATIONS · Firm: PARRY, ROMANI, DECONCINI & SYMMS
HR. 235, Permanent Internet Tax Freedom Act S. 431, Internet Tax Freedom Forever Act HR. 2029, Consolidated Appropriations Act 2016
Permanent Internet Tax Freedom Act
Client: VERIZON GOVERNMENT RELATIONS · Firm: PARRY, ROMANI, DECONCINI & SYMMS
HR. 235, Permanent Internet Tax Freedom Act S. 431, Internet Tax Freedom Forever Act
Alabama-Coushatta Tribe of Texas Equal and Fair Opportunity Settlement Act
Client: ALABAMA-COUSHATTA TRIBE OF TEXAS · Firm: PARRY, ROMANI, DECONCINI & SYMMS
S. 1457/H.R. 2684 - Alabama-Coushatta Tribe of Texas Equal & Fair Opportunity Settlement Act.
Stay in Place, Cut the Waste Act of 2015
Client: AMERICAN SOCIETY OF ASSN EXECUTIVES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
S. 1347, The Conference Accountability Act of 2013. Legislation related to federal travel and attendance by federal employees at meetings and conventions, and to information required to be posted on federal websites related to government sponsored conferences. No specific legislation introduced yet. H.R. 2810, Stay in Place, Cut the Waste, calls for agencies to cut travel budgets as much as 50% of 2015 levels by using videoconferencing as a substitute for face-to-face meetings. H.R. 2032, to institute spending limits and transparency requirements for Federal conference and travel expenditures, and for other purposes.
Stay in Place, Cut the Waste Act of 2015
Client: AMERICAN SOCIETY OF ASSN EXECUTIVES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
S. 1347, The Conference Accountability Act of 2013. Legislation related to federal travel and attendance by federal employees at meetings and conventions, and to information required to be posted on federal websites related to government sponsored conferences. No specific legislation introduced yet. H.R. 2810, Stay in Place, Cut the Waste, calls for agencies to cut travel budgets as much as 50% of 2015 levels by using videoconferencing as a substitute for face-to-face meetings. H.R. 2032, to institute spending limits and transparency requirements for Federal conference and travel expenditures, and for other purposes.
Stay in Place, Cut the Waste Act of 2015
Client: AMERICAN SOCIETY OF ASSN EXECUTIVES · Firm: PARRY, ROMANI, DECONCINI & SYMMS
S. 1347, The Conference Accountability Act of 2013. Legislation related to federal travel and attendance by federal employees at meetings and conventions, and to information required to be posted on federal websites related to government sponsored conferences. No specific legislation introduced yet. H.R. 2810, Stay in Place, Cut the Waste, calls for agencies to cut travel budgets as much as 50% of 2015 levels by using videoconferencing as a substitute for face-to-face meetings. H.R. 2032, to institute spending limits and transparency requirements for Federal conference and travel expenditures, and for other purposes.
Flex-IT 2 Act
Client: RESEARCH CORPORATION TECHNOLOGY · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.
Flex-IT 2 Act
Client: RESEARCH CORPORATION TECHNOLOGY · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.
Flex-IT 2 Act
Client: RESEARCH CORPORATION TECHNOLOGY · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.
Flex-IT 2 Act
Client: RESEARCH CORPORATION TECHNOLOGY · Firm: PARRY, ROMANI, DECONCINI & SYMMS
Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.
HR. 9, Innovation Act S. 1137, The Patent Act
Intellectual Property Issues
RESEARCH CORPORATION TECHNOLOGY via PARRY, ROMANI, DECONCINI & SYMMS
2019 · fourth_quarter · Q4
Intellectual Property Issues
AIDS HEALTHCARE FOUNDATION via PARRY, ROMANI, DECONCINI & SYMMS
2019 · fourth_quarter · Q4
340B Drug Pricing Program
Filing targets: SENATE
RESEARCH CORPORATION TECHNOLOGY via PARRY, ROMANI, DECONCINI & SYMMS
2019 · third_quarter · Q3
Intellectual Property Issues
AIDS HEALTHCARE FOUNDATION via PARRY, ROMANI, DECONCINI & SYMMS
2019 · third_quarter · Q3
Advocacy Regarding Middle Income Country Designation
340B Drug Pricing Program
Filing targets: SENATE
AKIN & PORTER PRODUCE via PARRY, ROMANI, DECONCINI & SYMMS
2019 · first_quarter · 1T
To obtain fumigation exemption on certain products
RESEARCH CORPORATION TECHNOLOGY via PARRY, ROMANI, DECONCINI & SYMMS
2019 · second_quarter · Q2
Intellectual Property Issues
AIDS HEALTHCARE FOUNDATION via PARRY, ROMANI, DECONCINI & SYMMS
2019 · second_quarter · Q2
340B Drug Pricing Program
Advocacy Regarding Middle Income Country Designation
Filing targets: SENATE
AKIN & PORTER PRODUCE via PARRY, ROMANI, DECONCINI & SYMMS
2019 · first_quarter · Q1
To obtain fumigation exemption on certain products
RESEARCH CORPORATION TECHNOLOGY via PARRY, ROMANI, DECONCINI & SYMMS
2019 · first_quarter · Q1
Intellectual Property Issues
GENERAL NUTRITION CENTER via PARRY, ROMANI, DECONCINI & SYMMS
2019 · first_quarter · Q1
For Upcoming Appropriations bill to fund the FDA
Filing targets: SENATE
AIDS HEALTHCARE FOUNDATION via PARRY, ROMANI, DECONCINI & SYMMS
2019 · first_quarter · Q1
340B Drug Pricing Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AKIN & PORTER PRODUCE via PARRY, ROMANI, DECONCINI & SYMMS
2018 · fourth_quarter · Q4
To obtain fumigation exemption on certain products
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
GENERAL NUTRITION CENTER via PARRY, ROMANI, DECONCINI & SYMMS
2018 · fourth_quarter · Q4
Trade issues affecting Farm Bill #H.R.265
Monitor amendments and legislation that may affect dietary supplements. No specific legislation introduced yet. Draft Guidance on NDI's. Appropriations issues affecting the supplement industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCK & ASSOCIATES via PARRY, ROMANI, DECONCINI & SYMMS
2018 · fourth_quarter · Q4
Appropriations to fund the FDA implementation of compounding pharmacy regulations: H.R. 1625, Consolidated Appropriations Act 2018
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
RESEARCH CORPORATION TECHNOLOGY via PARRY, ROMANI, DECONCINI & SYMMS
2018 · fourth_quarter · Q4
Intellectual Property issues.
AIDS HEALTHCARE FOUNDATION via PARRY, ROMANI, DECONCINI & SYMMS
2018 · fourth_quarter · Q4
340B Drug Pricing Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCK & ASSOCIATES via PARRY, ROMANI, DECONCINI & SYMMS
2018 · third_quarter · 3A
Appropriations to fund the FDA implementation of compounding pharmacy regulations: H.R. 1625, Consolidated Appropriations Act 2018
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
AKIN & PORTER PRODUCE via PARRY, ROMANI, DECONCINI & SYMMS
2018 · fourth_quarter · RR
To obtain fumigation exemption on certain products
GENERAL NUTRITION CENTER via PARRY, ROMANI, DECONCINI & SYMMS
2018 · third_quarter · Q3
Monitor amendments and legislation that may affect dietary supplements. No specific legislation introduced yet. Draft Guidance on NDI's. Appropriations issues affecting the supplement industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIDS HEALTHCARE FOUNDATION via PARRY, ROMANI, DECONCINI & SYMMS
2018 · third_quarter · Q3
340B Drug Pricing Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RESEARCH CORPORATION TECHNOLOGY via PARRY, ROMANI, DECONCINI & SYMMS
2018 · third_quarter · Q3
Intellectual Property issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERAL NUTRITION CENTER via PARRY, ROMANI, DECONCINI & SYMMS
2018 · second_quarter · Q2
H.R.2-Agriculture and Nutrition Act of 2018 (The Farm Bill) S3042 Agriculture and Nutrition Act of 2018 (The Farm Bill)
Monitor amendments and legislation that may affect dietary supplements. No specific legislation introduced yet. Draft guidance on NDI's. Appropriations issues affecting the supplement industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCK & ASSOCIATES via PARRY, ROMANI, DECONCINI & SYMMS
2018 · second_quarter · Q2
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Appropriations to fund the FDA implementation of compounding pharmacy regulations: H.R. 1625, Consolidated Appropriations Act 2018
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIDS HEALTHCARE FOUNDATION via PARRY, ROMANI, DECONCINI & SYMMS
2018 · second_quarter · Q2
340B Drug Pricing Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON GOVERNMENT RELATIONS via PARRY, ROMANI, DECONCINI & SYMMS
2018 · second_quarter · 2T
Net Neutrality, no specific legislation as yet.
VERIZON GOVERNMENT RELATIONS via PARRY, ROMANI, DECONCINI & SYMMS
2018 · second_quarter · Q2
Net Neutrality, no specific legislation as yet.
RESEARCH CORPORATION TECHNOLOGY via PARRY, ROMANI, DECONCINI & SYMMS
2018 · second_quarter · Q2
Intellectual Property issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON GOVERNMENT RELATIONS via PARRY, ROMANI, DECONCINI & SYMMS
2018 · first_quarter · Q1
Net Neutrality, no specific legislation as yet.
Filing targets: SENATE
ROCK & ASSOCIATES via PARRY, ROMANI, DECONCINI & SYMMS
2018 · first_quarter · Q1
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Appropriations to fund the FDA implementation of compounding pharmacy regulations; H.R. 1625, Consolidated Appropriations Act, 2018.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RESEARCH CORPORATION TECHNOLOGY via PARRY, ROMANI, DECONCINI & SYMMS
2018 · first_quarter · Q1
Intellectual Property issues.
Filing targets: SENATE
GENERAL NUTRITION CENTER via PARRY, ROMANI, DECONCINI & SYMMS
2018 · first_quarter · Q1
Issues related to the Supplemental Nutrition Assistance Program (SNAP) and the Women, Infants and Children Program (WIC).
Monitor amendments and legislation that may affect dietary supplements. No specific legislation introduced yet. Draft guidance on NDI's. Appropriations issues affecting the supplement industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRANDT MILES via PARRY, ROMANI, DECONCINI & SYMMS
2018 · first_quarter · 1T
Matters regarding the Federal Home Loan Mortgage Corp. No current or anticipated legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIDS HEALTHCARE FOUNDATION via PARRY, ROMANI, DECONCINI & SYMMS
2018 · first_quarter · Q1
Department of Labor, Health, Human Services, and Education, and Related Agencies Appropriations Act, FY 2018 - Support funding for medical treatments for HIV positive patients.
340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON GOVERNMENT RELATIONS via PARRY, ROMANI, DECONCINI & SYMMS
2017 · fourth_quarter · Q4
H.R. 1, Tax Cuts and Jobs Act. (An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.)
Cyber security in general, no specific legislation as yet.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRANDT MILES via PARRY, ROMANI, DECONCINI & SYMMS
2017 · third_quarter · Q3
Matters regarding the Federal Home Loan Mortgage Corp. No current or anticipated legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCK & ASSOCIATES via PARRY, ROMANI, DECONCINI & SYMMS
2017 · fourth_quarter · Q4
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Appropriations to fund the FDA implementation of compounding pharmacy regulations.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RESEARCH CORPORATION TECHNOLOGY via PARRY, ROMANI, DECONCINI & SYMMS
2017 · fourth_quarter · Q4
Intellectual Property issues.
Filing targets: SENATE
GENERAL NUTRITION CENTER via PARRY, ROMANI, DECONCINI & SYMMS
2017 · fourth_quarter · Q4
Issues related to the Supplemental Nutrition Assistance Program (SNAP) and the Women, Infants and Children Program (WIC).
Monitor amendments and legislation that may affect dietary supplements. No specific legislation introduced yet. Appropriations issues affecting the supplement industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRANDT MILES via PARRY, ROMANI, DECONCINI & SYMMS
2017 · fourth_quarter · Q4
Matters regarding the Federal Home Loan Mortgage Corp. No current or anticipated legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRANDT MILES via PARRY, ROMANI, DECONCINI & SYMMS
2017 · third_quarter · RR
Matters regarding the Federal Home Loan Mortgage Corporation (Freddie Mac). No current or anticipated applicable legislation.
VERIZON GOVERNMENT RELATIONS via PARRY, ROMANI, DECONCINI & SYMMS
2017 · third_quarter · Q3
Cyber security in general, no specific legislation as yet.
Corporate Tax Reform. No specific legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SICPA SECURINK CORP via PARRY, ROMANI, DECONCINI & SYMMS
2017 · third_quarter · 3T
Monitored and opposed legislative efforts affecting U.S. currency; specifically provisions which sought to eliminate the dollar bill and expand the circulation of dollar coins. Monitored provisions in the budget resolution affecting the scoring of proposals that would eliminate the dollar bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) via PARRY, ROMANI, DECONCINI & SYMMS
2017 · third_quarter · 3T
General issues related to health; and issues related to the need for research into clinical tools to diagnose and assess the severity of atopic dermatitis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCK & ASSOCIATES via PARRY, ROMANI, DECONCINI & SYMMS
2017 · third_quarter · Q3
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Appropriations to fund the FDA implementation of compounding pharmacy regulations.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RESEARCH CORPORATION TECHNOLOGY via PARRY, ROMANI, DECONCINI & SYMMS
2017 · third_quarter · Q3
Intellectual Property issues.
Filing targets: SENATE
GENERAL NUTRITION CENTER via PARRY, ROMANI, DECONCINI & SYMMS
2017 · third_quarter · Q3
Monitor amendments and legislation that may affect dietary supplements. No specific legislation introduced yet. Appropriations issues affecting the supplement industry.
Issues related to the Supplemental Nutrition Assistance Program (SNAP) and the Women, Infants and Children Program (WIC).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIDS HEALTHCARE FOUNDATION via PARRY, ROMANI, DECONCINI & SYMMS
2017 · third_quarter · Q3
Reauthorization and modifications to the Ryan White Patient Equity and Choice Act (no specific legislation introduced yet). 340B Drug Pricing Program.
Department of Labor, Health, Human Services, and Education, and Related Agencies Appropriations Act, FY 2018 - Support funding for medical treatments for HIV positive patients. Support appropriate funding for the ADAP program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON GOVERNMENT RELATIONS via PARRY, ROMANI, DECONCINI & SYMMS
2017 · second_quarter · Q2
Cyber security in general, no specific legislation as yet.
Corporate Tax Reform. No specific legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SICPA SECURINK CORP via PARRY, ROMANI, DECONCINI & SYMMS
2017 · second_quarter · Q2
Monitored and opposed legislative efforts affecting U.S. currency; specifically provisions which sought to eliminate the dollar bill and expand the circulation of dollar coins. Monitored provisions in the budget resolution affecting the scoring of proposals that would eliminate the dollar bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) via PARRY, ROMANI, DECONCINI & SYMMS
2017 · second_quarter · Q2
General issues related to health; and issues related to the need for research into clinical tools to diagnose and assess the severity of atopic dermatitis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCK & ASSOCIATES via PARRY, ROMANI, DECONCINI & SYMMS
2017 · second_quarter · Q2
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Appropriations to fund the FDA implementation of compounding pharmacy regulations.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RESEARCH CORPORATION TECHNOLOGY via PARRY, ROMANI, DECONCINI & SYMMS
2017 · second_quarter · Q2
Intellectual Property issues.
Filing targets: SENATE
GENERAL NUTRITION CENTER via PARRY, ROMANI, DECONCINI & SYMMS
2017 · second_quarter · Q2
Issues related to the Supplemental Nutrition Assistance Program (SNAP) and the Women, Infants and Children Program (WIC).
Monitor amendments and legislation that may affect dietary supplements. No specific legislation introduced yet. Appropriations issues affecting the supplement industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIDS HEALTHCARE FOUNDATION via PARRY, ROMANI, DECONCINI & SYMMS
2017 · second_quarter · Q2
Reauthorization and modifications to the Ryan White Patient Equity and Choice Act (no specific legislation introduced yet). 340B Drug Pricing Program.
Department of Labor, Health, Human Services, and Education, and Related Agencies Appropriations Act, FY 2018 - Support funding for medical treatments for HIV positive patients. Support appropriate funding for the ADAP program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON GOVERNMENT RELATIONS via PARRY, ROMANI, DECONCINI & SYMMS
2017 · first_quarter · Q1
Corporate Tax Reform. No specific legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SICPA SECURINK CORP via PARRY, ROMANI, DECONCINI & SYMMS
2017 · first_quarter · Q1
Monitored and opposed legislative efforts affecting U.S. currency; specifically provisions which sought to eliminate the dollar bill and expand the circulation of dollar coins. Monitored provisions in the budget resolution affecting the scoring of proposals that would eliminate the dollar bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) via PARRY, ROMANI, DECONCINI & SYMMS
2017 · first_quarter · Q1
Issues related to the 21st Century Cures Initiative, including all provisions of H.R. 6, To accelerate the discovery, development, and delivery of 21st century cures and for other purposes (21st Century Cures Act). Issues related to the need for research into clinical tools to diagnose and assess the severity of atopic dermatitis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RESEARCH CORPORATION TECHNOLOGY via PARRY, ROMANI, DECONCINI & SYMMS
2017 · first_quarter · Q1
Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.
Filing targets: SENATE
GENERAL NUTRITION CENTER via PARRY, ROMANI, DECONCINI & SYMMS
2017 · first_quarter · Q1
Monitor amendments and legislation that may affect dietary supplements. No specific legislation introduced yet.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIDS HEALTHCARE FOUNDATION via PARRY, ROMANI, DECONCINI & SYMMS
2017 · first_quarter · Q1
Reauthorization and modifications to the Ryan White Patient Equity and Choice Act (no specific legislation introduced yet). 340B Drug Pricing Program.
Department of Labor, Health, Human Services, and Education, and Related Agencies Appropriations Act, FY 2016 - Support funding for medical treatments for HIV positive patients. Support appropriate funding for the ADAP program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCK & ASSOCIATES via PARRY, ROMANI, DECONCINI & SYMMS
2017 · first_quarter · Q1
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet.
Appropriations to fund the FDA Implementation of compounding pharmacy regulations. No specific legislation introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON GOVERNMENT RELATIONS via PARRY, ROMANI, DECONCINI & SYMMS
2016 · fourth_quarter · Q4
S. 1137, The Patent Act
S. 851, Digital Goods and Tax Services Fairness Act H.R. 1643, Digital Goods and Tax Services Fairness Act
S. 356, Electronic Communications Privacy Act Amendments Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SICPA SECURINK CORP via PARRY, ROMANI, DECONCINI & SYMMS
2016 · fourth_quarter · Q4
Monitored and opposed legislative efforts affecting U.S. currency; specifically provisions which sought to eliminate the dollar bill and expand the circulation of dollar coins. Monitored provisions in the budget resolution affecting the scoring of proposals that would eliminate the dollar bill. S. 1888, Unified Savings and Accountability Act or the USA Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) via PARRY, ROMANI, DECONCINI & SYMMS
2016 · fourth_quarter · Q4
Issues related to the 21st Century Cures Initiative, including all provisions of H.R. 6, To accelerate the discovery, development, and delivery of 21st century cures and for other purposes (21st Century Cures Act). Issues related to the need for research into clinical tools to diagnose and assess the severity of atopic dermatitis. Issues related to insulin and vaccines, no specific legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCK & ASSOCIATES via PARRY, ROMANI, DECONCINI & SYMMS
2016 · fourth_quarter · Q4
Appropriations (H.R. 5054 and S. 2956) to fund the FDA implementation of compounding pharmacy regulations.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RESEARCH CORPORATION TECHNOLOGY via PARRY, ROMANI, DECONCINI & SYMMS
2016 · fourth_quarter · Q4
Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.
Filing targets: SENATE
GENERAL NUTRITION CENTER via PARRY, ROMANI, DECONCINI & SYMMS
2016 · fourth_quarter · Q4
Monitor amendments and legislation that may affect dietary supplements. No specific legislation introduced yet.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIDS HEALTHCARE FOUNDATION via PARRY, ROMANI, DECONCINI & SYMMS
2016 · fourth_quarter · Q4
Department of Labor, Health, Human Services, and Education, and Related Agencies Appropriations Act, FY 2016 - Support funding for medical treatments for HIV positive patients. Support appropriate funding for the ADAP program.
Reauthorization and modifications to the Ryan White Patient Equity and Choice Act (no specific legislation introduced yet). 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) via PARRY, ROMANI, DECONCINI & SYMMS
2016 · third_quarter · Q3
Monitored consideration of patent legislation; international intellectual property issues; general issues related to patent settlements; and all provisions of H.R. 9, the Innovation Act; and S. 1137, Protecting American Talent and Entrepeneurship Act of 2015.
General issues related to corporate tax reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON GOVERNMENT RELATIONS via PARRY, ROMANI, DECONCINI & SYMMS
2016 · third_quarter · Q3
S. 356, Electronic Communications Privacy Act Amendments Act of 2015
S. 851, Digital Goods and Tax Services Fairness Act H.R. 1643, Digital Goods and Tax Services Fairness Act
HR. 9, Innovation Act S. 1137, The Patent Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SICPA SECURINK CORP via PARRY, ROMANI, DECONCINI & SYMMS
2016 · third_quarter · Q3
Monitored and opposed legislative efforts affecting U.S. currency; specifically provisions which sought to eliminate the dollar bill and expand the circulation of dollar coins. Monitored provisions in the budget resolution affecting the scoring of proposals that would eliminate the dollar bill. S. 1888, Unified Savings and Accountability Act or the USA Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCK & ASSOCIATES via PARRY, ROMANI, DECONCINI & SYMMS
2016 · third_quarter · Q3
Proposals to amend the Controlled Substances Act to clarify the definition of "dispense" to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. No specific legislation yet.
Appropriations (H.R. 5054 and S. 2956) to fund the FDA implementation of compounding pharmacy regulations.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
RESEARCH CORPORATION TECHNOLOGY via PARRY, ROMANI, DECONCINI & SYMMS
2016 · third_quarter · Q3
Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.
Filing targets: SENATE
GENERAL NUTRITION CENTER via PARRY, ROMANI, DECONCINI & SYMMS
2016 · third_quarter · Q3
Monitor amendments and legislation that may affect dietary supplements. No specific legislation introduced yet.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIDS HEALTHCARE FOUNDATION via PARRY, ROMANI, DECONCINI & SYMMS
2016 · third_quarter · Q3
Department of Labor, Health, Human Services, and Education, and Related Agencies Appropriations Act, FY 2016 - Support funding for medical treatments for HIV positive patients. Support appropriate funding for the ADAP program.
Reauthorization and modifications to the Ryan White Patient Equity and Choice Act (no specific legislation introduced yet). 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) via PARRY, ROMANI, DECONCINI & SYMMS
2016 · second_quarter · Q2
Monitored consideration of patent legislation; international intellectual property issues; general issues related to patent settlements; and all provisions of H.R. 9, the Innovation Act; and S. 1137, Protecting American Talent and Entrepeneurship Act of 2015.
General issues related to corporate tax reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON GOVERNMENT RELATIONS via PARRY, ROMANI, DECONCINI & SYMMS
2016 · second_quarter · Q2
S. 356, Electronic Communications Privacy Act Amendments Act of 2015 H.R. 699, Email Privacy Act
HR. 9, Innovation Act S. 1137, The Patent Act
S. 851, Digital Goods and Tax Services Fairness Act H.R. 1643, Digital Goods and Tax Services Fairness Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERAL NUTRITION CENTER via PARRY, ROMANI, DECONCINI & SYMMS
2016 · second_quarter · Q2
Monitor amendments and legislation that may affect dietary supplements. No specific legislation introduced yet.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SICPA SECURINK CORP via PARRY, ROMANI, DECONCINI & SYMMS
2016 · second_quarter · Q2
Monitored and opposed legislative efforts affecting U.S. currency; specifically provisions which sought to eliminate the dollar bill and expand the circulation of dollar coins. Monitored provisions in the budget resolution affecting the scoring of proposals that would eliminate the dollar bill. S. 1888, Unified Savings and Accountability Act or the USA Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RESEARCH CORPORATION TECHNOLOGY via PARRY, ROMANI, DECONCINI & SYMMS
2016 · second_quarter · Q2
Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.
Filing targets: SENATE
AIDS HEALTHCARE FOUNDATION via PARRY, ROMANI, DECONCINI & SYMMS
2016 · second_quarter · Q2
Reauthorization and modifications to the Ryan White Patient Equity and Choice Act (no specific legislation introduced yet). 340B Drug Pricing Program.
Department of Labor, Health, Human Services, and Education, and Related Agencies Appropriations Act, FY 2016 - Support funding for medical treatments for HIV positive patients. Support appropriate funding for the ADAP program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCK & ASSOCIATES via PARRY, ROMANI, DECONCINI & SYMMS
2016 · second_quarter · Q2
Proposals to amend the Controlled Substances Act to clarify the definition of "dispense" to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. No specific legislation yet.
Appropriations (H.R. 5054 and S. 2956) to fund the FDA implementation of compounding pharmacy regulations.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) via PARRY, ROMANI, DECONCINI & SYMMS
2016 · first_quarter · Q1
General issues related to corporate tax reform.
Monitored consideration of patent legislation; international intellectual property issues; general issues related to patent settlements; and all provisions of H.R. 9, the Innovation Act; and S. 1137, Protecting American Talent and Entrepeneurship Act of 2015.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON GOVERNMENT RELATIONS via PARRY, ROMANI, DECONCINI & SYMMS
2016 · first_quarter · Q1
S. 356, Electronic Communications Privacy Act Amendments Act of 2015 H.R. 699, Email Privacy Act
HR. 235, Permanent Internet Tax Freedom Act S. 431, Internet Tax Freedom Forever Act
HR. 9, Innovation Act S. 1137, The Patent Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SICPA SECURINK CORP via PARRY, ROMANI, DECONCINI & SYMMS
2016 · first_quarter · Q1
Monitored and opposed legislative efforts affecting U.S. currency; specifically provisions which sought to eliminate the dollar bill and expand the circulation of dollar coins. Monitored provisions in the budget resolution affecting the scoring of proposals that would eliminate the dollar bill. S. 1888, Unified Savings and Accountability Act or the USA Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCK & ASSOCIATES via PARRY, ROMANI, DECONCINI & SYMMS
2016 · first_quarter · Q1
Proposals to amend the Controlled Substances Act to clarify the definition of "dispense" to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. No specific legislation yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet.
Appropriations to fund the FDA implementation of compounding pharmacy regulations.
RESEARCH CORPORATION TECHNOLOGY via PARRY, ROMANI, DECONCINI & SYMMS
2016 · first_quarter · Q1
Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.
Filing targets: SENATE
GENERAL NUTRITION CENTER via PARRY, ROMANI, DECONCINI & SYMMS
2016 · first_quarter · Q1
Monitor amendments and legislation that may affect dietary supplements. No specific legislation introduced yet.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIDS HEALTHCARE FOUNDATION via PARRY, ROMANI, DECONCINI & SYMMS
2016 · first_quarter · Q1
Reauthorization and modifications to the Ryan White Patient Equity and Choice Act (no specific legislation introduced yet). 340B Drug Pricing Program.
Department of Labor, Health, Human Services, and Education, and Related Agencies Appropriations Act, FY 2016 - Support funding for medical treatments for HIV positive patients. Support appropriate funding for the ADAP program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON GOVERNMENT RELATIONS via PARRY, ROMANI, DECONCINI & SYMMS
2015 · fourth_quarter · Q4
S. 356, Electronic Communications Privacy Act Amendments Act of 2015
HR. 9, Innovation Act S. 1137, The Patent Act
HR. 235, Permanent Internet Tax Freedom Act S. 431, Internet Tax Freedom Forever Act HR. 2029, Consolidated Appropriations Act 2016
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SICPA SECURINK CORP via PARRY, ROMANI, DECONCINI & SYMMS
2015 · fourth_quarter · Q4
Monitored and opposed legislative efforts affecting U.S. currency; specifically provisions which sought to eliminate the dollar bill and expand the circulation of dollar coins. Monitored provisions in the budget resolution affecting the scoring of proposals that would eliminate the dollar bill. S. 1888, Unified Savings and Accountability Act or the USA Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RESEARCH CORPORATION TECHNOLOGY via PARRY, ROMANI, DECONCINI & SYMMS
2015 · fourth_quarter · Q4
Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.
Filing targets: SENATE
NC9 GROUP TRUST via PARRY, ROMANI, DECONCINI & SYMMS
2015 · fourth_quarter · Q4
Rocket technology -- no pending or applicable legislation, at this time.
Rocket technology -- no pending or applicable legislation, at this time.
Rocket technology -- no pending or applicable legislation, at this time.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERAL NUTRITION CENTER via PARRY, ROMANI, DECONCINI & SYMMS
2015 · fourth_quarter · Q4
Monitor amendments and legislation that may affect dietary supplements. No specific legislation introduced yet.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIDS HEALTHCARE FOUNDATION via PARRY, ROMANI, DECONCINI & SYMMS
2015 · fourth_quarter · Q4
Reauthorization and modifications to the Ryan White Patient Equity and Choice Act (no specific legislation introduced yet). 340B Drug Pricing Program.
Department of Labor, Health, Human Services, and Education, and Related Agencies Appropriations Act, FY 2016 - Support funding for medical treatments for HIV positive patients. Support appropriate funding for the ADAP program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF ASSN EXECUTIVES via PARRY, ROMANI, DECONCINI & SYMMS
2015 · fourth_quarter · Q4
S. 1347, The Conference Accountability Act of 2013. Legislation related to federal travel and attendance by federal employees at meetings and conventions, and to information required to be posted on federal websites related to government sponsored conferences. No specific legislation introduced yet. H.R. 2810, Stay in Place, Cut the Waste, calls for agencies to cut travel budgets as much as 50% of 2015 levels by using videoconferencing as a substitute for face-to-face meetings. H.R. 2032, to institute spending limits and transparency requirements for Federal conference and travel expenditures, and for other purposes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCK & ASSOCIATES via PARRY, ROMANI, DECONCINI & SYMMS
2015 · fourth_quarter · Q4
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet.
Appropriations to fund the FDA implementation of compounding pharmacy regulations.
VERIZON GOVERNMENT RELATIONS via PARRY, ROMANI, DECONCINI & SYMMS
2015 · third_quarter · Q3
HR. 9, Innovation Act S. 1137, The Patent Act
HR. 235, Permanent Internet Tax Freedom Act S. 431, Internet Tax Freedom Forever Act
S. 356, Electronic Communications Privacy Act Amendments Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Proposals to amend the Controlled Substances Act to clarify the definition of "dispense" to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. No specific legislation yet.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE